Expansion Potential Perrigo España is part of a global leader in OTC health with a presence in 28 countries and a portfolio of 225+ brands, suggesting strong cross-border collaboration opportunities and potential for regionaldistribution partnerships, private label expansion, and shared supply chain synergies.

Pharmacy Channel Strength Longstanding partnerships with over 100,000 pharmacies and parafarmacias across Europe indicate a well-established retail network ideal for upsell of OTC staples and coordinated marketing programs, including exclusive SKUs and in-store promotions.

Popular Brand Portfolio A broad lineup including Compeed, Relec, Antigrippine, Lactacyd, Ella One, and Sebamed presents multiple touchpoints for category penetration, bundle deals, and cross-category cross-selling with pharmacy customers seeking reliable self-care solutions.

Scale and Footprint With 51-200 employees and regional footprint in Iberia, there is potential to tailor localized product launches, regulatory-ready offerings, and fast cycle pilots to accelerate time-to-market for new OTC products in Portugal and Spain.

Revenue Opportunity Current revenue range indicates a mid-market presence; combined with Perrigo’s global scale, there is an opportunity to pursue higher-margin SKUs, private-label programs, and tiered pricing models for large pharmacy chains and distributor partners.